Improving Safety of Antivenom in People Bitten by Snakes

Sponsor
University of Kelaniya (Other)
Overall Status
Completed
CT.gov ID
NCT00270777
Collaborator
(none)
1,000
1
37
27

Study Details

Study Description

Brief Summary

A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, & hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Drug: adrenaline, promethazine, hydrocortisone
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Low Dose Adrenaline, Promethazine, & Hydrocortisone (Alone and in Combination) to Prevent Acute Adverse Reactions to Antivenom in People Bitten by Snakes: Randomised, Double Blind, Placebo-Controlled Trial
Study Start Date :
Mar 1, 2005
Actual Primary Completion Date :
Apr 1, 2008
Actual Study Completion Date :
Apr 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Frequency of severe reactions to antivenom in the first 48 hours []

Secondary Outcome Measures

  1. Frequency of moderate & severe reactions to antivenom in the first 48 hours []

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Above 12 years of age

  • Patients admitted to hospital after snake bite in whom antivenom is indicated

  • Patients who give informed consent

Exclusion Criteria:
  • Patients who are pregnant or nursing

  • Patients who are currently taking beta- or alpha-adrenoceptor antagonists, or tricyclic antidepressants

  • Patients in whom adrenaline may be contraindicated (this may include patients with the following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and tachyarrhythmias)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Trials Unit, University of Kelaniya Ragama Sri Lanka

Sponsors and Collaborators

  • University of Kelaniya

Investigators

  • Principal Investigator: Asita de Silva, University of Kelaniya

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00270777
Other Study ID Numbers:
  • 178A07
First Posted:
Dec 28, 2005
Last Update Posted:
Jun 5, 2008
Last Verified:
Jun 1, 2008

Study Results

No Results Posted as of Jun 5, 2008